Literature DB >> 24644189

Uncertainty and anxiety in the cancer of unknown primary patient journey: a multiperspective qualitative study.

A Richardson1, R Wagland2, R Foster2, J Symons3, C Davis4, L Boyland5, C Foster2, J Addington-Hall2.   

Abstract

BACKGROUND: Patients with cancer of unknown primary (CUP) have metastatic malignant disease without an identifiable primary site; it is the fourth most common cause of cancer death.
OBJECTIVES: To explore patients' informal and professional carers' experiences of CUP to inform development of evidence-based, patient-centred care.
METHODS: Qualitative study involving development of multiple exploratory case studies, each comprising a patient and nominated informal and professional carers, with contextual data extracted from medical records.
RESULTS: 17 CUP patients, 14 informal and 13 professional carers participated in the study. Two inter-related themes distinct to CUP emerged: uncertainty and continuity of care. In the absence of a primary diagnosis, patients and informal carers experienced uncertainty regarding prognosis, possible recurrence and the primary's hereditary potential. Professional carers experienced difficulty communicating uncertainty to patients, ambiguity in deciding optimal treatment plans in the absence of trial data and a test or treat dilemma: when to discontinue seeking the primary and start treatment. Common problems with care continuity were amplified for CUP patients relating to coordination, accountability and timeliness of care. The remit of multidisciplinary teams (MDTs) often excluded CUP, leading to "MDT tennis" where patients were "bounced" between MDTs.
CONCLUSIONS: The experience of those with CUP is distinctive and it can serve to amplify some of the issues encountered by people with cancer. The clinical uncertainties related to CUP compound existing shortcomings in continuity of care, increasing the likelihood of a disrupted patient journey. However, while little can be done to overcome uncertainty, more could be done to address issues regarding continuity of care. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Mesh:

Year:  2013        PMID: 24644189     DOI: 10.1136/bmjspcare-2013-000482

Source DB:  PubMed          Journal:  BMJ Support Palliat Care        ISSN: 2045-435X            Impact factor:   3.568


  8 in total

1.  Carcinoma of Unknown Primary with EML4-ALK Fusion Response to ALK Inhibitors.

Authors:  Peng Zhao; Ling Peng; Wei Wu; Yi Zheng; Weiqin Jiang; Hangyu Zhang; Zhou Tong; Lulu Liu; Ruobing Ma; Liping Wang; Ming Yao; Kai Wang; Weijia Fang; Liming Wu
Journal:  Oncologist       Date:  2019-01-24

2.  Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy.

Authors:  David Levy; Haryana M Dhillon; Anna Lomax; Michael Marthick; Catriona McNeil; Steven Kao; Judith Lacey
Journal:  Support Care Cancer       Date:  2018-09-04       Impact factor: 3.603

3.  Nationwide survey on family caregiver-perceived experiences of patients with cancer of unknown primary site.

Authors:  Kyoko Ishida; Kazuki Sato; Hirokazu Komatsu; Tatsuya Morita; Tatsuo Akechi; Megumi Uchida; Kento Masukawa; Naoko Igarashi; Yoshiyuki Kizawa; Satoru Tsuneto; Yasuo Shima; Mitsunori Miyashita; Shoko Ando
Journal:  Support Care Cancer       Date:  2022-04-28       Impact factor: 3.603

4.  Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin.

Authors:  Qinghua Xu; Jinying Chen; Shujuan Ni; Cong Tan; Midie Xu; Lei Dong; Lin Yuan; Qifeng Wang; Xiang Du
Journal:  Mod Pathol       Date:  2016-03-18       Impact factor: 7.842

5.  Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary.

Authors:  Kanwal Raghav; Hyunsoo Hwang; Alexandre A Jácome; Eric Bhang; Anneleis Willett; Ryan W Huey; Nishat P Dhillon; Jignesh Modha; Brandon Smaglo; Aurelio Matamoros; Jeannelyn S Estrella; Justin Jao; Michael J Overman; Xuemei Wang; F Anthony Greco; Jonathan M Loree; Gauri R Varadhachary
Journal:  Clin Cancer Res       Date:  2021-04-15       Impact factor: 12.531

6.  Associations of Uncertainty With Psychological Health and Quality of Life in Older Adults With Advanced Cancer.

Authors:  Haydee C Verduzco-Aguirre; Dilip Babu; Supriya G Mohile; Javier Bautista; Huiwen Xu; Eva Culakova; Beverly Canin; Yingzi Zhang; Megan Wells; Ronald M Epstein; Paul Duberstein; Colin McHugh; William Dale; Alison Conlin; James Bearden; Jeffrey Berenberg; Mohamedtaki Tejani; Kah Poh Loh
Journal:  J Pain Symptom Manage       Date:  2020-08-19       Impact factor: 5.576

Review 7.  Public Health Perspective of Primary Palliative Care: A Review through the Lenses of General Practitioners.

Authors:  Shrikant Atreya; Soumitra Datta; Naveen Salins
Journal:  Indian J Palliat Care       Date:  2022-05-26

8.  Differences in experiences of care between patients diagnosed with metastatic cancer of known and unknown primaries: mixed-method findings from the 2013 cancer patient experience survey in England.

Authors:  Richard Wagland; Mike Bracher; Allison Drosdowsky; Alison Richardson; John Symons; Linda Mileshkin; Penny Schofield
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.